Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus-Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
- PMID: 33426402
- PMCID: PMC7783564
- DOI: 10.1016/j.ekir.2020.10.012
Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus-Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
Figures


Similar articles
-
Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.Transpl Infect Dis. 2019 Dec;21(6):e13182. doi: 10.1111/tid.13182. Epub 2019 Oct 15. Transpl Infect Dis. 2019. PMID: 31556214
-
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428. Haematologica. 2016. PMID: 27365460 Free PMC article. Review.
-
Successful low-dose chemotherapy for refractory Epstein-Barr virus-related post-transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott-Aldrich syndrome.Clin Case Rep. 2021 May 24;9(5):e04111. doi: 10.1002/ccr3.4111. eCollection 2021 May. Clin Case Rep. 2021. PMID: 34084507 Free PMC article.
-
Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation.Curr Res Transl Med. 2019 Nov;67(4):145-148. doi: 10.1016/j.retram.2019.03.001. Epub 2019 Mar 11. Curr Res Transl Med. 2019. PMID: 30871955
-
Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.Eur J Haematol. 2018 Sep;101(3):283-290. doi: 10.1111/ejh.13131. Epub 2018 Aug 3. Eur J Haematol. 2018. PMID: 29949208 Review.
References
-
- Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374:2256–2267. - PubMed
-
- Beyar-Katz O., Davila E.K., Zuckerman T. Adult nephrotic syndrome after hematopoietic stem cell transplantation: renal pathology is the best predictor of response to therapy. Biol Blood Marrow Transplant. 2016;22:975–981. - PubMed
-
- Wong E., Lasica M., He S.Z. Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation. Intern Med J. 2016;46:737–741. - PubMed
-
- Brukamp K. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol. 2006;1:685–694. - PubMed
-
- Styczynski J., Gil L., Tridello G. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clin Infect Dis. 2013;57:794–802. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources